Clint recently had the opportunity to chat with Rob MacNaughton, the CEO of Calibrate, about the groundbreaking approach his company is taking in the weight loss industry by combining powerful GLP-1 drugs like Wegovy and Ozempic with clinician-led lifestyle interventions. Rob shares insights into the advantages and disadvantages of these medications, the impressive results Calibrate has achieved, and the importance of addressing the root causes of obesity. We also delve into Rob's diverse background, the challenges and benefits of leading a fully remote company, and the role of AI in enhancing member experience and operational efficiency.Timestamps:00:00 - Introduction00:09 - Rob's background and the rise of GLP-1 drugs01:03 - Calibrate's unique approach to weight loss02:29 - Impressive results and published data04:00 - Safety and efficacy of GLP-1 drugs05:14 - What a typical week looks like for Calibrate members07:19 - Rob's journey to Calibrate12:36 - The importance of addressing the root cause of obesity14:25 - A day in the life of a remote CEO16:35 - Leadership in a remote environment19:39 - Talent acquisition in a remote setting23:00 - The role of AI in Calibrate's operations26:03 - Long-term planning with AI27:10 - The importance of giving and taking chances

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related